Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
831,812
-
Shares change
-
-223,451
-
Total reported value, excl. options
-
$65,599,188
-
Value change
-
-$16,638,970
-
Put/Call ratio
-
140%
-
Number of buys
-
31
-
Number of sells
-
-31
-
Price
-
$78.88
Significant Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q1 2021
98 filings reported holding PJP - INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS as of Q1 2021.
INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 831,812 shares
.
Largest 10 shareholders include Peak Asset Management, LLC (127,123 shares), LPL Financial LLC (83,320 shares), BANK OF AMERICA CORP /DE/ (62,853 shares), UBS Group AG (60,955 shares), GOLDMAN SACHS GROUP INC (50,133 shares), MORGAN STANLEY (40,946 shares), Federation des caisses Desjardins du Quebec (36,867 shares), CREDIT SUISSE AG/ (24,572 shares), COMMONWEALTH EQUITY SERVICES, LLC (23,312 shares), and WELLS FARGO & COMPANY/MN (22,249 shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.